Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
Abstract Epithelial-mesenchymal transition (EMT) is designated as one of the prime causes of chemoresistance in many cancers. In our previous study we established that cisplatin resistance in ovarian cancer (OC) is associated with EMT using sensitive OV90 cells and its resistant counterparts OV90Cis...
Saved in:
Main Authors: | Taha Umair Wani, Hyun-Yi Kim, Geum-Hwa Lee, Young Je Lim, Han-Jung Chae, Ji-Ye Kim, Hyonok Yoon |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-01-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-025-87388-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Composition analysis and mechanism of Guizhi Fuling capsule in anti-cisplatin-resistant ovarian cancer
by: Lei Dou, et al.
Published: (2025-02-01) -
Cisplatin resistance alters ovarian cancer spheroid formation and impacts peritoneal invasion
by: Lydia C. Powell, et al.
Published: (2025-02-01) -
Pyrogallol acts as a novel anticancer factor to enhance the sensitivity to cisplatin in ovarian cancer cells through inducing miR-15a upregulation
by: Azin Shirani, et al.
Published: (2025-01-01) -
KAT2B inhibits proliferation and invasion via inactivating TGF-β/Smad3 pathway-medicated autophagy and EMT in epithelial ovarian cancer
by: Yuqin Yao, et al.
Published: (2025-01-01) -
Mebendazole Exerts Anticancer Activity in Ovarian Cancer Cell Lines via Novel Girdin-Mediated AKT/IKKα/β/NF-κB Signaling Axis
by: Rahul Gupta, et al.
Published: (2025-01-01)